There Could Be Fake Botox in the US

30 12 2012

“Healthcare professionals and hospitals have a duty to use approved medications when treating patients,” says Richard P. Console – a New Jersey injury attorney. “Knowingly using a counterfeit drug or failing to inspect medication properly, puts patients at risk for additional injuries and could lead to malpractice actions down the road. Certainly, Botox is no compound to mess around with if you’re not absolutely sure it’s safe.”

Federal regulators are saying that the botox that possibly more than 350 doctors and practices in the US received from a supplier in Canada does not carry federal approval and is most likely fake. This alleged anti-wrinkle drug was shipped by a company owned by Canada Drugs and does not have the approval of the FDA. Basically that means that the agency cannot guarantee its effectiveness or safety.  The following distributors belong to Canada Drugs – Bridgewater Medical, Clinical Care, A+ Health Supplies, and QSP (Quality Specialty Products).

Earlier this year the company Canada Drugs was in the middle of the shipping of other unapproved pharmaceuticals. In February, I wrote about shipments of a cancer drug called Avastin. In the US there have been plenty of malpractice suits due to the administration of fake/unapproved drugs. Console & Hollawell P.C. is a personal injury law firm helping victims of medical malpractice in New Jersey. Their attorneys have secured more than $30,000,000 in deserved compensation for their clients.

The FDA said, “Health care professionals, pharmacies, and wholesalers/distributors are valuable partners in efforts to protect consumers from the risks of unsafe or ineffective products that may be stolen, counterfeit, contaminated, or improperly stored and transported. The receipt of suspicious or unsolicited offers from unknown suppliers should be questioned, and extra caution should be taken when considering them.” Any suspected criminal activity should be reported to the Office of Criminal Investigations (OCI) by phoning 1-800-551-3989, or via the OCI Web Site.




Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: